Congratulations to the 2017 ACRM Distinguished Lecturer in Cancer Rehabilitation and Survivorship Care Award Winner Dr. Michael Stubblefield!
"Dr. Stubblefield is an internationally renowned expert in cancer rehabilitation. He has led many important initiatives to advance the field."
—Julie Silver, MD, Associate Professor, Harvard Medical School; Associate Chair and Director of Cancer Rehabilitation, Spaulding Rehabilitation Hospital
Michael D. Stubblefield, MD
Medical Director for Cancer Rehabilitation, Kessler Institute for Rehabilitation;
National Medical Director for Cancer Rehabilitation, Select Medical
Dr. Michael D. Stubblefield is a nationally and internationally recognized leader in the field of cancer rehabilitation. His clinical expertise is in the identification, evaluation and rehabilitation of neuromuscular, musculoskeletal, pain and functional disorders resulting from cancer and its treatment, particularly those caused by radiation and neurotoxic chemotherapy. He is an expert electromyographer and performs procedures such as botulinum toxin (Botox) injections for the relief of pain and spasm in cancer survivors.
Dr. Stubblefield graduated with honors from Brown University in Providence, RI, where he double majored in biology and philosophy. He received his medical degree from the Columbia University College of Physicians and Surgeons and completed a combined residency in internal medicine and physical medicine and rehabilitation (PM&R) at Columbia Presbyterian Medical Center in New York City. He is triple board certified in (PM&R), internal medicine, and electrodiagnostic medicine (EMG).
Dr. Stubblefield worked at Memorial Sloan Kettering Cancer Center for nearly 14 years and was the Chief of the Rehabilitation Medicine Service. He joined Kessler Institute as Medical Director of Cancer Rehabilitation in 2015. He also serves as the National Medical Director of Cancer Rehabilitation for Select Medical where he oversees the development of comprehensive cancer rehabilitation programs across the organization’s national network of rehabilitation facilities.
Named one of America's top doctors, America's top doctors for cancer, and New York metro area’s top doctors by Castle Connolly for many years, Dr. Stubblefield is an accomplished researcher, and has published extensively in medical rehabilitation, oncology, pain management, palliative care, and neurophysiology. He serves on the editorial board of the journal Muscle and Nerve, and is a peer reviewer for more than 30 journals. Most notably, Dr. Stubblefield is the senior editor of Cancer Rehabilitation: Principles and Practice, the only comprehensive textbook in the field, and has also authored numerous review articles and book chapters in the field of cancer rehabilitation.
Dr. Stubblefield has given hundreds of lectures both nationally and internationally on a wide range of cancer rehabilitation-related topics. He has also served on the Board of the American Association of Neuromuscular and Electrodiagnostic Medicine and as Chair of the Medical Council of the American Association of Physical Medicine and Rehabilitation.
Michael D. Stubblefield, MD, will receive the 2017 Distinguished Lecturer in Cancer Rehabilitation & Survivorship Care award in recognition of his contributions to the advancement of oncology care. Dr. Stubblefield will present, The Past, Present, and Future of Cancer Rehabilitation, at the ACRM Annual Conference in Atlanta
“Dr. Stubblefield has been a leader in the area of cancer rehabilitation for over a decade. His academic work and clinical growth has helped to place cancer rehabilitation at the forefront of care for both the rehabilitation and oncology communities.”
—Vishwa S. Raj, MD, Associate Professor, Chief, Section of Rehabilitation, Department of Supportive Care, The Levine Cancer Institute; Medical Director of Oncology Rehabilitation, Vice-Chair for Clinical Operations in Department of PM&R, Carolinas Rehabilitation Medical Center
ACRM Annual Conference, Progress in Rehabilitation Research (PIRR#2017)
CORE: 25 - 28 OCT 2018 // HILTON ATLANTA, USA // PRE-CONFERENCE 23 - 25 OCT